EcoDrugPlus

Adrenoceptor Beta 1

Ensembl ID : ENSNGAG00000018440
Gene Symbol: ADRB1
3 Cross references
161 Possible Orthologues:

Advanced Glycosylation End-Product Specific Receptor

Ensembl ID : ENSNGAG00000022564
Gene Symbol: AGER
3 Cross references
169 Possible Orthologues:

Alcohol Dehydrogenase Class-3

Ensembl ID : ENSNGAG00000007953
Gene Symbol: LOC103728053
3 Cross references
400 Possible Orthologues:

Aldo-Keto Reductase Family 1 Member B1

Ensembl ID : ENSNGAG00000014511
Gene Symbol: LOC103736561
3 Cross references
429 Possible Orthologues:

Amiloride-Sensitive Amine Oxidase [Copper-Containing]

Ensembl ID : ENSNGAG00000002359
Gene Symbol: LOC103745300
3 Cross references
203 Possible Orthologues:

Amiloride-Sensitive Amine Oxidase [Copper-Containing]-Like

Ensembl ID : ENSNGAG00000021501
Gene Symbol: LOC103745301
3 Cross references
202 Possible Orthologues:

Amiloride-Sensitive Amine Oxidase [Copper-Containing]-Like

Ensembl ID : ENSNGAG00000015976
Gene Symbol: LOC103745358
3 Cross references
202 Possible Orthologues:

Amine Oxidase Copper Containing 3

Ensembl ID : ENSNGAG00000012544
Gene Symbol: AOC3
3 Cross references
321 Possible Orthologues:

Amyloid Beta Precursor Protein

Ensembl ID : ENSNGAG00000015861
Gene Symbol: APP
3 Cross references
276 Possible Orthologues:

Androgen Receptor

Ensembl ID : ENSNGAG00000001772
Gene Symbol: AR
2 Cross references
276 Possible Orthologues:

Angiotensin Ii Receptor Type 1

Ensembl ID : ENSNGAG00000018677
Gene Symbol: AGTR1
3 Cross references
195 Possible Orthologues:

Angiotensin Ii Receptor Type 2

Ensembl ID : ENSNGAG00000008929
Gene Symbol: AGTR2
3 Cross references
191 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).